Tag: 4-Aminopyridine

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to 4-Aminopyridine

Analysts See $0.96 EPS for Acorda Therapeutics, Inc. (ACOR)

Added to Collection on: 2018-01-19 17:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Piper Jaffray Initiates “Hold” Rating for Acorda Therapeutics (NASDAQ:ACOR) With a $22.0 Price ...

Added to Collection on: 2018-03-09 05:11:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Time to Reconsider Acorda Therapeutics Inc (NASDAQ:ACOR) After More Short Sellers?

Added to Collection on: 2018-04-16 21:07:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Cantor Fitzgerald Has Just Reaffirmed $17.0000 Target Price Per Share on Acorda Therapeutics ...

Added to Collection on: 2018-05-03 01:03:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
On October, 31 Analysts See $0.02 EPS for Acorda Therapeutics, Inc. (ACOR)

Added to Collection on: 2018-10-24 08:56:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Acorda Therapeutics Inc (ACOR) Holdings Lifted by Alps Advisors Inc.

Added to Collection on: 2019-03-05 07:40:14

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Two Sigma Investments LP Acquires New Holdings in Acorda Therapeutics Inc (ACOR)

Added to Collection on: 2019-03-30 21:47:58

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
BNP Paribas Arbitrage SA Reduces Stock Position in Acorda Therapeutics Inc (NASDAQ:ACOR)

Added to Collection on: 2019-09-07 01:15:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details